Evidence map›Paper›PMID 37146942›Full record

ArticleAmerican journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons2023

The expanded role of the transplant pharmacist: A 10-year follow-up.

Alicia Beth Lichvar, Mary Moss Chandran, Elizabeth A Cohen, Barrett R Crowther, Christina Teeter Doligalski, Amanda J Condon Martinez, Lisa M M Potter, David J Taber, Rita R Alloway

Abstract read
In one paragraph

Article in American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors.

Alicia Beth LichvarCenter for Transplantation, University of California San Diego Health, La Jolla, California, USA. Electronic address: alichvar@health.ucsd.edu.
Mary Moss ChandranDepartment of Pharmacy, UNC Health, Chapel Hill, North Carolina, USA.
Elizabeth A CohenDepartment of Transplantation, Yale New Haven Hospital, New Haven, Connecticut, USA.
Barrett R CrowtherDepartment of Pharmacy, University of Colorado Health, Aurora, Colorado, USA.
Christina Teeter DoligalskiDepartment of Pharmacy, UNC Health, Chapel Hill, North Carolina, USA.
Amanda J Condon MartinezKidneylink, U.S. Renal Care Plano, Texas, USA.
Lisa M M PotterDepartment of Pharmacy, University of Chicago Medicine, Chicago, Illinois, USA.
David J TaberDivision of Transplantation, Department of Surgery, Medical University of South Carolina, Charleston, South Carolina, USA.
Rita R AllowayDivision of Nephrology, Department of Internal Medicine, University of Cincinnati, Cincinnati, Ohio, USA.

Funding

Multifaceted Intervention to Improve Graft Outcome Disparities in African American Kidney Transplants (MITIGAAT)R01DK134326 · NIDDK · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI John W. McGillicuddy · 2023 to 2026
$2.5M
NIDDK NIH HHS R01 DK134326
6 · The paper itself

Abstract

The role of the transplant pharmacist is recognized by transplant programs, governmental groups, and professional organizations as an essential part of the transplant multidisciplinary team. This role has evolved drastically over the last decade with the advent of major advances in the science of transplantation and the growth of the field, which necessitate expanded pharmacy services to meet the needs of patients. Data now exist within all realms of the phases of care for a transplant recipient regarding the utility and benefit of a solid organ transplant (SOT) pharmacist. Furthermore, governing bodies now have the opportunity to use Board Certification in Solid Organ Transplant Pharmacotherapy as a mechanism to identify and recognize specialty knowledge and expertise within the field of SOT pharmacotherapy. The purpose of this paper is to provide an overarching review of the current and future state of SOT pharmacy while also identifying major changes to the profession, forthcoming challenges, and expected areas of growth.

Indexed as

Organ TransplantationPharmacistsCertificationFollow-Up StudiesHumansclinical pharmacytransplantationtransplant pharmacist

Identifiers

PMID37146942
PMCPMC11851232

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.